Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions
-
Azucar Minerals Ltd. Announces Change of Name to Mustang Minerals Limited
-
Avicanna Announces Sponsorship of University of Calgary THC Dose Finding Clinical Trial
-
Signing Day Sports and BlockchAIn Provide Update on Expected Ticker Symbol Transition and Common Stock Trading Schedule
-
Enlight Secures $304 Million in Project Financing for the Crimson Orchard Project in Idaho, USA
-
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
-
Quipt Home Medical Completes the Previously Announced Arrangement With Affiliates of Kingswood and Forager
-
Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer
-
Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results
-
SiriusPoint Announces Creation of Global P&C Programs and London Market Specialty Divisions
-
Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca
-
Auction result of Treasury Bills - RIKV 26 0618 - RIKV 26 0916
-
Nasus Pharma Announces Positive Top Line Data from Phase 2 Clinical Study of NS002: Achieves Significantly Superior and Faster Epinephrine Delivery Compared to EpiPen® with Accelerated Speed to Thera
-
AnyTech365 helps spearhead first global online anti-fraud platform
-
Dyadic Applied BioSolutions Announces Commercial Distribution Partnership with IBT Bioservices
-
iSpring Unveils Its First Outdoor Portable Filter Straw: The IFS-B Personal Water Filter Straw
-
WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE WTI CRUDE OIL 3X DAILY SHORT SECURITIES ISIN: XS2819844387
-
Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Minimum Price Deficiency
-
Aurora Spine Corporation to Participate in the 38th Annual ROTH Conference
-
Capital increase – new Articles of Association
-
NEURONES: Declaration of transactions on treasury shares (March 9 to 13, 2026)
-
CytomX Therapeutics Announces 2025 Financial Results and Provides Business Update
-
SAIC Announces Fourth Quarter and Full Fiscal Year 2026 Results
-
Cyber Acoustics Releases WC-1000 Webcam, Built to Work Seamlessly with Headsets or Speakerphones
-
VivoPower Announces Effectiveness of New Stock Ticker “VIVO” and Corporate Name Change
-
Clarios Appoints Chris Courts as Chief Legal Officer
-
Bloomway AI Announces Public Beta of CinePro: Infusing Cinematic Expertise into AIGC to Redefine the "Lean Cinema" Workflow
-
Bloomway AI Announces Public Beta of CinePro: Infusing Cinematic Expertise into AIGC to Redefine the "Lean Cinema" Workflow
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
-
CytomX’s Varsetatug Masetecan (EpCAM PROBODY® ADC) Continues to Demonstrate Positive Data Supporting Potential as a New Treatment Option in Late-Line Colorectal Cancer
-
GFM Announces Non-Brokered Private Placement
-
Nuclear Vision Acquires Manganese Carbonate Projects in Slovakia’s “Battery Belt”
-
REPEAT - Media Advisory: Concerned residents mount protests outside Liberal MP offices nationwide for action against the threat of U.S. private health care
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
-
Wallbridge Mining Announces Drilling Has Commenced at Martiniere
-
Monte Rosa Therapeutics Announces Clinical Supply Agreement to Support Phase 2 Trial Evaluating MRT-2359 in Combination with Apalutamide for the Treatment of Metastatic Castration-Resistant Prostate C
-
Neumora Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, March 30, 2026
-
Structure Therapeutics Reports Positive Topline Data from Phase 2 ACCESS II Trial with Once-Daily Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron
-
Tower Semiconductor Teams up with Oriole to Advance AI Infrastructure and Networking with Nanosecond Optical Circuit Switching
-
Aurora Mobile Establishes Japanese Subsidiary to Redefine AI-Powered Customer Interaction and Security
-
NRx Pharmaceuticals (Nasdaq:NRXP) Confirms Path to New Drug Application with Real World Data and Broader Proposed Indication for NRX-100 (ketamine) Following Type C FDA Meeting
-
Zenas BioPharma Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
-
Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at UChicago Medicine
-
Tilray Brands Enters Agreement to Acquire BrewDog’s Key U.S. Assets, Expanding Its U.S. Craft Beer Platform
-
Plug Executive Leadership to Participate in Investor Conferences in Europe and Washington, D.C.
-
Xanadu and TELUS Collaborate to Advance Quantum Data Centre Infrastructure in Canada
-
Eldorado Gold Announces Receipt of the Operating Authorization for the Ormaque Deposit at the Lamaque Complex
-
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
